In three breast cancer cell lines and 176 primary tumor cell lines, Sharif et al. found these cell lines had high levels of the rate-limiting enzyme of the NAD(+) salvage pathways, nicotinamide phosphoribosyltransferase (NAMPT) and lower levels of p73, both correlating to poor survival rates. The gene discussed is NAMPT; the disease is breast carcinoma.